Christopher Sears, chief scientific officer of Ambergen, has joined the scientific advisory board of WaferGen. Previously, he held joint academic appointments in the field of oncology at Children's Hospital Boston, the Broad Institute, Harvard Medical School, and the Dana Farber Cancer Institute, where he was responsible for directing projects and operations of the clinical genomics group. He has also served as a scientific advisor for the Department of Justice and the Federal Bureau of Investigation in the areas of genetics and statistics for the development of high-throughput comparative forensics genomic technologies. Sears holds a doctorate in biochemistry and molecular and cellular biology from Harvard University.
Paired Ends: Nov 10, 2009
Nov 10, 2009